scholarly journals Discovering Small-Molecule Estrogen Receptor α/Coactivator Binding Inhibitors: High-Throughput Screening, Ligand Development, and Models for Enhanced Potency

ChemMedChem ◽  
2011 ◽  
Vol 6 (4) ◽  
pp. 654-666 ◽  
Author(s):  
Aiming Sun ◽  
Terry W. Moore ◽  
Jillian R. Gunther ◽  
Mi-Sun Kim ◽  
Eric Rhoden ◽  
...  
Keyword(s):  
Estrogen Receptor ◽  
Small Molecule ◽  
High Throughput ◽  
High Throughput Screening ◽  
Estrogen Receptor Α ◽  
Coactivator Binding Inhibitors ◽  
Binding Inhibitors

Small Molecule Inhibitors of Estrogen Receptor Action Identified by High-Throughput Screening

2011 ◽  
pp. P1-61-P1-61
Author(s):  
Neal D Andruska ◽  
Mathew M Cherian ◽  
Chengjian Mao ◽  
Milu T Cherian ◽  
David J Shapiro
Keyword(s):  
Estrogen Receptor ◽  
Small Molecule ◽  
High Throughput ◽  
High Throughput Screening ◽  
Small Molecule Inhibitors ◽  
Receptor Action

scholarly journals Perturbation of Estrogen Receptor α Localization with Synthetic Nona-Arginine LXXLL-Peptide Coactivator Binding Inhibitors

2009 ◽  
Vol 16 (7) ◽  
pp. 702-711 ◽  
Author(s):  
Maëlle Carraz ◽  
Wilbert Zwart ◽  
Trang Phan ◽  
Rob Michalides ◽  
Luc Brunsveld
Keyword(s):  
Estrogen Receptor ◽  
Estrogen Receptor Α ◽  
Coactivator Binding Inhibitors ◽  
Binding Inhibitors

A Short-Incubation Reporter-Gene Assay for High-Throughput Screening of Estrogen Receptor-α Antagonists

2005 ◽  
Vol 3 (4) ◽  
pp. 393-400 ◽  
Author(s):  
Xiaoqing Shi ◽  
Wei Zheng ◽  
Jonathan E. Schneeweis ◽  
Paul A. Fischer ◽  
Berta Strulovici ◽  
...  
Keyword(s):  
Estrogen Receptor ◽  
Reporter Gene ◽  
High Throughput ◽  
High Throughput Screening ◽  
Estrogen Receptor Α ◽  
Reporter Gene Assay ◽  
Gene Assay

scholarly journals Synthesis of Biphenyl Proteomimetics as Estrogen Receptor-α Coactivator Binding Inhibitors

2009 ◽  
Vol 11 (23) ◽  
pp. 5370-5373 ◽  
Author(s):  
Anna B. Williams ◽  
Patrick T. Weiser ◽  
Robert N. Hanson ◽  
Jillian R. Gunther ◽  
John A. Katzenellenbogen
Keyword(s):  
Estrogen Receptor ◽  
Estrogen Receptor Α ◽  
Coactivator Binding Inhibitors ◽  
Binding Inhibitors

scholarly journals Development of a Novel High-Throughput Screen and Identification of Small-Molecule Inhibitors of the Gα–RGS17 Protein–Protein Interaction Using AlphaScreen

2011 ◽  
Vol 16 (8) ◽  
pp. 869-877 ◽  
Author(s):  
Duncan I. Mackie ◽  
David L. Roman
Keyword(s):  
Small Molecule ◽  
High Throughput ◽  
Protein Interaction ◽  
High Throughput Screening ◽  
Drug Targets ◽  
Screening Method ◽  
Fold Increase ◽  
Rgs Proteins ◽  
High Throughput Screen ◽  
Protein Protein Interaction

In this study, the authors used AlphaScreen technology to develop a high-throughput screening method for interrogating small-molecule libraries for inhibitors of the Gαo–RGS17 interaction. RGS17 is implicated in the growth, proliferation, metastasis, and the migration of prostate and lung cancers. RGS17 is upregulated in lung and prostate tumors up to a 13-fold increase over patient-matched normal tissues. Studies show RGS17 knockdown inhibits colony formation and decreases tumorigenesis in nude mice. The screen in this study uses a measurement of the Gαo–RGS17 protein–protein interaction, with an excellent Z score exceeding 0.73, a signal-to-noise ratio >70, and a screening time of 1100 compounds per hour. The authors screened the NCI Diversity Set II and determined 35 initial hits, of which 16 were confirmed after screening against controls. The 16 compounds exhibited IC50 <10 µM in dose–response experiments. Four exhibited IC50 values <6 µM while inhibiting the Gαo–RGS17 interaction >50% when compared to a biotinylated glutathione-S-transferase control. This report describes the first high-throughput screen for RGS17 inhibitors, as well as a novel paradigm adaptable to many other RGS proteins, which are emerging as attractive drug targets for modulating G-protein-coupled receptor signaling.

scholarly journals A small molecule UPR modulator for diabetes identified by high throughput screening

2021 ◽  
Author(s):  
Valeria Marrocco ◽  
Tuan Tran ◽  
Siying Zhu ◽  
Seung Hyuk Choi ◽  
Ana M. Gamo ◽  
...  
Keyword(s):  
Small Molecule ◽  
High Throughput ◽  
High Throughput Screening

High-Throughput Screening to Identify Small Molecules That Selectively Inhibit APOL1 Protein Level in Podocytes

2021 ◽  
pp. 247255522110262
Author(s):  
Jonathan Choy ◽  
Yanqing Kan ◽  
Steve Cifelli ◽  
Josephine Johnson ◽  
Michelle Chen ◽  
...  
Keyword(s):  
Small Molecule ◽  
High Throughput ◽  
High Throughput Screening ◽  
Screening Strategy ◽  
Time Resolved ◽  
Protein Levels ◽  
Increased Risk ◽  
Compound Screening ◽  
High Throughput Screens ◽  
Screening Library

High-throughput phenotypic screening is a key driver for the identification of novel chemical matter in drug discovery for challenging targets, especially for those with an unclear mechanism of pathology. For toxic or gain-of-function proteins, small-molecule suppressors are a targeting/therapeutic strategy that has been successfully applied. As with other high-throughput screens, the screening strategy and proper assays are critical for successfully identifying selective suppressors of the target of interest. We executed a small-molecule suppressor screen to identify compounds that specifically reduce apolipoprotein L1 (APOL1) protein levels, a genetically validated target associated with increased risk of chronic kidney disease. To enable this study, we developed homogeneous time-resolved fluorescence (HTRF) assays to measure intracellular APOL1 and apolipoprotein L2 (APOL2) protein levels and miniaturized them to 1536-well format. The APOL1 HTRF assay served as the primary assay, and the APOL2 and a commercially available p53 HTRF assay were applied as counterscreens. Cell viability was also measured with CellTiter-Glo to assess the cytotoxicity of compounds. From a 310,000-compound screening library, we identified 1490 confirmed primary hits with 12 different profiles. One hundred fifty-three hits selectively reduced APOL1 in 786-O, a renal cell adenocarcinoma cell line. Thirty-one of these selective suppressors also reduced APOL1 levels in conditionally immortalized human podocytes. The activity and specificity of seven resynthesized compounds were validated in both 786-O and podocytes.

scholarly journals Design of High-Throughput Screening Assays and Identification of a SUMO1-Specific Small Molecule Chemotype Targeting the SUMO-Interacting Motif-Binding Surface

2015 ◽  
Vol 17 (4) ◽  
pp. 239-246 ◽  
Author(s):  
Aileen Y. Alontaga ◽  
Yifei Li ◽  
Chih-Hong Chen ◽  
Chen-Ting Ma ◽  
Siobhan Malany ◽  
...  
Keyword(s):  
Small Molecule ◽  
High Throughput ◽  
High Throughput Screening ◽  
Binding Surface ◽  
Screening Assays
Sign in / Sign up

Export Citation Format

Share Document